Timothy Mayleben, President & CEO, Director at Esperion, holds 122.70K shares in Esperion (Ticker: ESPR), holds ― shares in Landos Biopharma (Ticker: LABP), holds 24.38K shares in Marinus (Ticker: MRNS).
Timothy Mayleben latest transaction was an Uninformative Buy of $22.36K.
What was Timothy Mayleben's most profitable transaction?
Timothy Mayleben’s most profitable transaction was an Informative Buy of ESPR stock on May 5, 2016. The return on the trade was 143.90%.
What is Timothy Mayleben's role in Esperion?
Timothy Mayleben's role in Esperion is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.